On April 3, 2026, Ginkgo Bioworks Holdings, Inc. completed the acquisition of Biosecurity, contributing all its equity interests in exchange for approximately 20% of Tower Biosecurity’s equity. This transaction has resulted in Biosecurity's operations being classified as discontinued in Ginkgo's financial statements.